Literature DB >> 32045574

HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.

Tianhua Zhang1, Xiaoyu Tang1, Ling Mao1, Jin Chen1, Jie Kuang1, Xin Guo1, Danyan Xu1, Daoquan Peng2, Bilian Yu3.   

Abstract

BACKGROUND: The mechanism for an abnormal pattern of triglyceride (TG) metabolism in response to a meal still needs further investigation. Extensive pieces of evidence have shown that apolipoprotein CIII (apoCIII) is a critical modulator of plasma TG metabolism mostly by inhibiting the hydrolysis of TG. Little is known about the role of apoCIII contained in high density lipoprotein (HDL) in plasma TG metabolism after a meal.
METHODS: Fasting and 4-hour postprandial peripheral venous blood were collected in 91 subjects selected from our hospital. Serum lipid parameters, apoCIII levels and HDL subcomponents were tested by standard laboratory procedures, ELISA, and nuclear magnetic resonance (NMR), respectively. The t-test, and Non-parametric tests were performed to examine differences between groups, Pearson's correlation and multiple regression analysis were used to assess the correlations between apoCIII (HDL-associated or nonHDL-associated) and postprandial TG.
RESULTS: There was a significant increase in TG after a meal compared to fasting status [155.40(96.70-251.07) mg/dl.vs.118.53(83.38-173.29)mg/dl, p < 0.001]. However, the total apoCIII levels were unchanged before (11.56(7.89-16.22) mg/dl) and after a meal (11.66(7.75-16.02)mg/dl, p = 0.124), while a significant increase in HDL-associated apoCIII (HDL-apoCIII) was observed from fasting (5.25(3.92-7.83)mg/dl) to post-meal (6.46(4.57-8.76)mg/dl, p = 0.001). Unlike nonHDL-apoCIII, HDL-apoCIII was positively correlated with both fasting and postprandial plasma TG in subjects with baseline plasma TG > 118.53 mg/dl (R = 0.503, p < 0.001 for fasting, R = 0.584, p < 0.001 for postprandial). Besides, in the subjects who had an abnormal TG response to a meal, which was defined as postprandial plasma TG increase of>30% compared to baseline TG levels, postprandial HDL-apoCIII was also increased significantly [5.37(3.52-7.02)mg/dl.vs.6.64(4.61-8.86)mg/dl, p = 0.001]. The enrichment of apoCIII in HDL led to changes of TG, cholesterol, free cholesterol, phospholipid and apoAII contents in HDL particles defined by NMR.
CONCLUSION: Enrichment of apoCIII in HDL particles potentially plays an independent role in postprandial hypertriglyceridemia.
Copyright © 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein CIII (apoCIII); Atherosclerotic cardiovascular disease (ASCVD); High density lipoprotein (HDL); Hypertriglyceridemia

Mesh:

Substances:

Year:  2020        PMID: 32045574     DOI: 10.1016/j.clinbiochem.2020.02.004

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study.

Authors:  Aleksandra Cieluch; Aleksandra Uruska; Marcin Nowicki; Ewa Wysocka; Paweł Niedźwiecki; Agata Grzelka-Woźniak; Justyna Flotyńska; Dorota Zozulińska-Ziółkiewicz
Journal:  Arch Med Sci       Date:  2020-10-29       Impact factor: 3.707

2.  ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease.

Authors:  Xin Guo; Zhijie Huang; Jin Chen; Jiarui Hu; Die Hu; Daoquan Peng; Bilian Yu
Journal:  Front Cardiovasc Med       Date:  2022-06-29

3.  Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance.

Authors:  Jin Chen; Jie Kuang; Xiaoyu Tang; Ling Mao; Xin Guo; Qin Luo; Daoquan Peng; Bilian Yu
Journal:  Lipids Health Dis       Date:  2020-06-10       Impact factor: 3.876

4.  Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.

Authors:  Julius L Katzmann; Christian M Werner; Tatjana Stojakovic; Winfried März; Hubert Scharnagl; Ulrich Laufs
Journal:  Lipids Health Dis       Date:  2020-05-30       Impact factor: 3.876

Review 5.  The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.

Authors:  Jan Borén; Chris J Packard; Marja-Riitta Taskinen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.